US › Healthcare

Scienture Holdings, Inc. (SCNX)

US · Healthcare · Pharmaceutical Retailers

$0.31-5.44%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$343,639

Net profit

$-2.8M

EPS

$-0.07

EPS estimate

$-0.09

Net margin

-821.3%

EPS came in at -0.07 against a street estimate of -0.09 — a beat of 22.2%.

Key statistics

Market cap

$14.3M

Forward P/E

21.8

P/B

0.22

Book value

$1.56

EPS (TTM)

$-2.03

52-week high

$2.60

52-week low

$0.24

50-day MA

$0.39

200-day MA

$0.43

Beta

3.98

Analyst view

with an average price target of $1.50.

Shareholding

Insiders

13.17%

Institutions

5.30%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.05%
Vanguard Capital Management, LLC	0.99%
Vanguard Fiduciary Trust Co	0.48%
Citadel Advisors Llc	0.40%
UBS Group AG	0.26%
Virtu Financial LLC	0.21%
XTX Topco Ltd	0.12%
TWO SIGMA SECURITIES, LLC	0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scienture Holdings, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.